The company has appointed Jim Rechtin as President and COO, effective January 8, 2024, as part of a CEO transition plan. Rechtin will eventually take over as CEO, with the current CEO, Bruce Broussard, remaining as a strategic advisor until 2025.
Humana says Rechtin, a healthcare industry veteran, brings substantial experience, having served as President and CEO of Envision Healthcare. This move aims to support Humana's growth and integrated care strategy.
See Also: Stocks In The Red, Bonds On The Rise As Investors Brace for FOMC Minutes
Meanwhile under Broussard's leadership, Humana says the company has expanded from an insurer to a broader healthcare company, notably growing its Medicare Advantage membership and enhancing healthcare delivery services.
According to data from Benzinga Pro, Humana has a 52-week high of $571.30 and a 52-week low of $423.29.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
